Purpose: The aim of this study was to establish the prevalence and association of age-related macular degeneration (AMD) and obesity which was not studied extensively in Indian population over 60 years of age. Methods: This was a cross-sectional, population-based study. A total of 4791 patients with gradable fundus photography were included. All patients underwent detailed ophthalmic examination and AMD was graded with retinal photographs. Grading of AMD was done according to the International ARM Epidemiological Study Group and staged based on grading in worse eye. The association of AMD severity and obesity (based on body mass index, waist-hip ratio, waist circumference, isolated abdominal obesity, isolated generalized obesity, and combined obesity) was assessed. The main outcome variable was an association between the presence and severity of AMD with different grades of obesity. Results: No direct significant association was noted between the presence and severity of AMD and any obesity indices. Subgroup analyses based on lifestyle patterns and common systemic pathologies in AMD population were done. Late AMD was significantly associated with tobacco consumption in population with combined obesity (P = 0.033 and odds ratio = 2.998). Conclusion: No direct association was noted between the presence or severity of AMD and obesity in South Indian population. However, indirect associations between the severity of AMD and combined obesity were found.
Age-related macular degeneration (AMD) is a complex disease with genetic and environmental etiology and is the leading cause of irreversible blindness in developed countries and in a few developing countries in the elderly age group. [1] It is a progressive neurodegenerative ocular disease which affects the central portion of retina and choroid. [2] Although few treatments are available for AMD, including specific nutritional intake and dietary supplements for dry AMD and anti-vascular endothelial growth factor (VEGF) therapies for neovascular form, without new treatments or preventive strategies, the rates of vision loss are expected to rise in the future. For this reason, a better understanding of the pathogenesis is essential to develop preventive measures to reduce the burden of the disease.
Chronic low-grade inflammation state was found to be involved in the complex pathogenesis of AMD. Obesity being a pro-inflammatory state contributes to the disease process. [3] Previous studies have shown an association of both generalized and abdominal obesities with AMD. [4, 5] Studies had reported that waist-to-hip ratio (WHR), which is a measure of abdominal obesity, had a stronger relationship with AMD than body mass index (BMI), which is a measure of generalized obesity. [4, 5] Evidence shows that the prevalence of obesity, abdominal, general, and combined, differs in various populations and ethnic groups.
It has been postulated that Asians are prone to visceral fat accumulation, which might be the reason for the greatest prosperity to develop diseases such as diabetes at relatively low BMI values. [6] To the best of our knowledge, no population-based studies had been done which show the association of various types of obesity and AMD in India. The aim of this study is to establish the association of both abdominal and generalized obesities with AMD in Indian population.
Methods
A population-based, cross-sectional study of 5495 persons from Indian population, above the age of 60 years, was done between 2009 and 2011. The study design and research methodology were described in detail elsewhere. [7] This study was approved by the institutional review board, a written consent was obtained from the participants following the Declaration of Helsinki.
Of the 5495 patients, 4791 patients with gradable retinal photographs were included in the study. A detailed questionnaire enumerating the medical history, general physical examination, educational status, occupation, history of smoking, and consumption of tobacco and alcohol was admitted. The medical history data included the duration and treatment of diabetes mellitus, hypertension, and coronary artery disease. The ocular history included details of ocular complaints and past ocular treatment or surgery.
All the patients underwent a detailed ophthalmic evaluation, which includes assessment of visual acuity using modified Early Treatment Diabetic Retinopathy Study chart (Light House Low Vision Products, NY, USA), refraction, anterior-segment examination using a slit-lamp (Zeiss SL 130, Carl Zeiss, Jena, Germany), measurement of intraocular pressure (Zeiss AT 030 Applanation Tonometer; Carl Zeiss), and fundus examination using binocular indirect ophthalmoscope (Keeler Instruments Inc., Broomall, PA, USA).
Grading of lens opacification was done using the Lens
Opacities Classification System III (LOCS Chart III; Leo T Chylack, Harvard Medical School, Boston, MA, USA) by experienced ophthalmologists. A slit-lamp photography of the crystalline lens after dilatation was obtained in all patients for comparing it with LOCS chart III and grading was done accordingly. Retinal photographs were obtained after pupillary dilatation (Carl Zeiss fundus camera; FF-450, Germany). The grading of AMD was done by a single experienced (more than 5 years) vitreoretinal surgeon in accordance with the International ARM Epidemiological Study Group and staged based on the grading in the worst eye. [8] Anthropometric measurements such as weight (to the nearest 0.5 kg), height, waist, and hip measurements using a nonstretchable measuring tape (to the nearest centimeter) were obtained using standardized techniques. Based on BMI, waist circumference (WC), and WHR, the type of obesities were classified.
Definitions
• Early AMD: It is defined as the presence of drusen as discrete whitish-yellow spots located external to the neuroretina or retinal pigmented epithelium (RPE) or the presence of drusen with RPE abnormalities seen as areas of hyperpigmentation or hypopigmentation [8] • Late AMD: (a) Dry AMD: It is defined as the presence of geographic atrophy of the RPE in the absence of neovascularization. (b) Wet AMD: It is defined as the presence of RPE detachments, which may be associated with neurosensory retinal detachment, sub-RPE or subretinal neovascular membranes, and subpigment epithelial, subretinal, or intraretinal scar or glial tissue. Fibrin-like deposits and subretinal hemorrhages might be present which will not be related to other retinal vascular diseases [8] • BMI: It is calculated using the following formula: weight (in kg)/height (in m 2 ) • WC and hip circumference: The WC is the measurement of smallest horizontal circumference between the costal margins and the iliac crests at minimal respiration. And the greatest circumference, widest protrusion of the hip, was measured as hip girth • WHR: It is calculated by dividing the WC (in cm) by the hip circumference (in cm)
• Obesity: According to the World Health Organization Expert Consultation guidelines, obesity is defined based on BMI alone (BMI ≥23 kg/m 2 ), WC alone (men ≥90 cm and women ≥80 cm), and WHR alone (men ≥0.90 and women ≥0.85) [9, 10] • Isolated generalized obesity: It is defined as increased BMI with normal WC (BMI ≥23 kg/m 2 and WC in men <90 cm and women <80 cm) • Isolated abdominal obesity: It is defined as increased WC with normal BMI (WC in men ≥90 cm and women ≥80 cm and BMI ≤23 kg/m 2 ) • Combined obesity: It is defined as both increased WC and BMI (BMI ≥23 kg/m 2 and WC in men ≥90 cm and women ≥80 cm).
Statistical analysis
Statistical analyses were carried out using SPSS statistical software for Windows, Version 21.0 (IBM Corp, Released 2013, Armonk, NY, USA) and Microsoft Excel 2013 (Microsoft Corp, Redmond, WA, USA). For the categorical variables, Chi-square test and logistic regression analysis with step-wise forward method were used to find the association between AMD and obesity. For continuous variables, to compare difference between independent groups, Student's t-test for parametric data and Mann-Whitney U-test for nonparametric data were done. P < 0.05 was considered statistically significant.
Results Table 1a and b shows the demographic and baseline characteristics of both AMD and normal population. In Table 1a , the overall parameters of AMD population and normal population were compared. Statistically significant difference was noted between AMD and normal populations in parameters such as age, BMI in kg/m 2 , hip and WC in centimeter, proportion of smoking, tobacco and alcohol consumption, diabetes, hypertension, and obesity indices such as obesity based on BMI, WC, and combined obesity. In Table 1b , the parameters of both the groups were compared between males and females. Statistically significant difference between males and females was noted in characteristics such as age, BMI in kg/m 2 , hip circumference in centimeter, WHR, the proportion of smoking, alcohol consumption, hypertension, and all obesity indices with P < 0.05 in both the groups. The proportion of obesity indices was comparable between AMD and normal population. Fig. 1 shows the graphical representation of prevalence of various obesity indices in AMD population. In our study population, the prevalence of obesity based on WHR was more compared to normal, whereas the prevalence of obesity based on BMI, isolated generalized obesity, isolated abdominal obesity, and combined obesity was less compared to normal proportion in each group.
Binary logistic regression analysis was done to obtain the odds ratio (OR) and P value and to find any association of obesity with various types of obesity. The results are summarized in Table 2a . A total of 4791 patients for whom AMD was gradable were included in this analysis. Out of 4791, 3802 patients had no AMD and 989 patients had either early or late stage of AMD. No statistically significant association was noted between the presence of AMD and any obesity indices. A subanalysis was done to find if the stage of AMD was associated with either of the obesity indices, in overall population and in each gender. Table 2b shows the proportions of patients in each obesity index and their comparison between early AMD and late AMD. No significant associations were noted. The ORs were adjusted for age, diabetes status, smoking status, socioeconomic score, systolic blood pressure, and diastolic blood pressure. Table 3 shows the combined association of stage of AMD with various obesity indices and risk factors, adjusting for age. The risk factors such as smoking, alcohol and tobacco consumption, diabetes, and hypertension were compared with the stage of AMD (early and late) in the population with each obesity indices. Consumption of tobacco was significantly associated with late AMD in the population with combined obesity, with P = 0.033 and OR being 2.998 (1.091-8.238). No significant association was noted for other risk factors.
Discussion
This study estimates the prevalence of various obesity indices in AMD patients and its association with severity and risk factors of AMD. The prevalence of obesity was more in women when compared to men, which was statistically significant. No significant association was noted between any obesity indices and presence or severity of AMD. Association of AMD with obesity indices such as obesity based on BMI, WC, WHR, isolated generalized obesity, isolated abdominal obesity, and combined obesity was evaluated in our study. Previous studies had shown that the correlation of various obesity indices does not have a linear relationship. It was found that the correlation of BMI and central obesity varies from one individual to another. Age and gender have an influence on various obesity indices. Hence, we studied the association of AMD with possible obesity indices.
In our study, we adjusted for age, gender, smoking status, socioeconomic scoring, diabetes status, and blood pressure to find an association between the presence of various obesity indices and presence and severity of AMD. No statistically significant direct association was noted. Similar to our study, few case-control and cross-sectional studies had reported that there was no significant association between obesity and AMD. [11] [12] [13] However, many case-control or longitudinal studies [2, 5, [14] [15] [16] [17] and few cross-sectional studies [3, 13, 18] had shown a significant association between AMD and either one of the obesity indices. Table 4 shows the summary of previous studies done to determine the association between AMD and obesity.
Zhang et al. [1] did a meta-analysis of prospective studies on the association of obesity and AMD. They concluded that excess body weight may act as a potential risk factor for AMD incidence. They postulated from the previous studies that the secretion of pro-inflammatory messengers, such as monocyte chemoattractant protein-1 and tumor necrosis factor-α, was significantly elevated in obese individuals. The migration and infiltration of monocyte could be regulated by these pro-inflammatory factors, causing a disturbance in the function of the RPE which might contribute to retinal changes encountered in AMD. [19, 20] They had also described that increased adiposity on the distribution of macular carotenoids may partly be related to increased risk of AMD in obese individuals. [21] We did not find any association with risk factors such as smoking and alcohol consumption. Previous studies [22] [23] [24] [25] [26] had shown smoking to be a well-known risk factor for AMD progression. Smoking is known to affect the circulation of antioxidants. This leads to decrease in the levels of compounds with antioxidant capabilities in the body, thereby the protection of retina against oxidative damage is perturbed. [14] Severity of AMD was significantly associated with consumption of tobacco in the population with combined obesity. This infers that combined obesity is indirectly associated with AMD in addition to tobacco consumption. However, this study being a cross-sectional study, we could not find the relative risk of smoking and alcohol, which could be established well with a longitudinal study by assessing the progression of AMD in groups with and without risk factors.
We did not find any significant association of AMD with systemic diseases such as diabetes mellitus and hypertension. Increase in the risk of AMD progression with the presence of diabetes mellitus and hypertension in obesity category was reported in previous studies. [5, 19, 27] The novelty of the study is its design being population based which included both urban and rural populations of India over 60 years of age with large sample size. However, there are few limitations: (1) This being a cross-sectional study, the relative risk of AMD progression with the presence of obesity and other risk factors could not be assessed. This study restricted to measuring the occurrence rather than incidence of AMD. (2) Patients in early stage are usually asymptomatic and it is not easy to distinguish them only by routine ophthalmic examination. Thus, the true association of early AMD is more likely to be underestimated; however, to overcome this, we have highlighted both early and late AMD. (3) A higher level of BMI tends to be associated with other unhealthy behaviors, such as lower levels of physical activity, lower vegetable consumption, and higher alcohol consumption. Hence, it could be a confounding factor. However, these confounders could not be tested due to nonavailability of the data.
Conclusion
In the Indian population, presence or severity of AMD did not seem to directly relate to any of the obesity indices. However, there is an association between severity of AMD and consumption of tobacco in population with combined obesity. AMD, being a multifactorial etiology, should be more carefully studied with a longitudinal study with a similar design for prevention of its progression by altering the lifestyle-related risk factors.
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